Actively Recruiting
A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
Led by QurAlis Corporation · Updated on 2026-02-19
48
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
QRL-101-08 is a multiple ascending dose (MAD) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of a novel formulation of QRL-101 in healthy participants.
CONDITIONS
Official Title
A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 65 years inclusive at the time of signing the informed consent
- Clinical chemistry laboratory values within acceptable range for the population, as per investigator judgment
- Body mass index of 18 to 32 kg/m2 inclusive
- Willing and able to practice effective contraception
You will not qualify if you...
- Currently enrolled in any other clinical trial involving a study drug, off-label drug or device use, or other medical research incompatible with this study
- Participation in more than 4 studies a year or participation in a clinical trial within 1 month of the expected dosing date
- History or presence of medical illness including cardiovascular, hepatic, respiratory, hematological, endocrine, psychiatric, neurological disease, convulsions, or clinically significant laboratory abnormalities that preclude study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ICON plc.
Groningen, Netherlands, 9728 NZ
Actively Recruiting
Research Team
Q
QurAlis Corporation
CONTACT
S
Salah Hadi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here